January 11th 2024EP. 12: Evaluating Treatment Outcomes in Dry Eye Disease Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD; compare emerging therapies and traditional treatments for dry eye disease.
The Board appointed Parekh, 53, as CEO and MD for five years (till December 31, 2022). He will be the second non-founder executive of the $10-billion firm after the exit of the first non-promoter ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback